Showing results (261-270 of 994) with videos related to
Sort By:
Pageof 100
The Journal of Antimicrobial Chemotherapy|April 1, 1986
In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patientsK V Rolston, M E Alvarez, K C Hsu, et al.The American Journal of Medicine|February 1, 1988
Central nervous system histoplasmosis. An unappreciated complication of the acquired immunodeficiency syndromeE Anaissie, V Fainstein, T Samo, et al.The American Journal of Medicine|August 1, 1987
Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous cathetersJ F Hoy, K V Rolston, R L Hopfer, et al.Cancer|August 1, 1979
Treatment of acute leukemia in protected environment unitsG P Bodey, K B McCredie, M J Keating, et al.Clinical Pharmacology and Therapeutics|August 1, 1985
Clinical pharmacology of timentin (ticarcillin and clavulanic acid)G P Bodey, E Yeo, D H Ho, et al.Cancer Treatment Reports|August 1, 1980
Hepatotoxicity of hycanthone in patients with metastatic breast cancerM M Haq, S S Legha, C W Wiseman, et al.Clinical Pharmacology and Therapeutics|January 1, 1975
Clincal pharmacology of O2,2'-cyclocytidineD H Rodriguez, T L Loo, G P Bodey, et al.Cancer Clinical Trials|January 1, 1981
Phase I study of aziridinylbenzoquinone (NSC 182986)A Y Bedikian, G P Bodey, M A Burgess, et al.Cancer|October 1, 1978
The value of adriamycin in the treatment of diffuse malignant pleural mesotheliomaB S Yap, R S Benjamin, M A Burgess, et al.Infectious Disease Clinics of North America|September 15, 2000
Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasisD P Kontoyiannis, M A Luna, B I Samuels, et al.Pageof 100